Literature DB >> 16454739

Receptor-independent effects of endocannabinoids on ion channels.

Murat Oz1.   

Abstract

Endogenous cannabinoids (endocannabinoids), produced from membrane-bound precursors via calcium and/or G-protein dependent processes, mimic the effects of cannabinoids by activating cannabinoid CB(1) and/or CB(2) receptors. Several reports however, also indicate that endocannabinoids can produce effects that are independent of cannabinoid receptors. Thus, in pharmacologically relevant concentrations, endocannabinoids have been demonstrated to modulate the functional properties of voltage-gated ion channels including Ca(2+) channels, Na(+) channels and various types of K(+) channels, and ligand-gated ion channels such as 5-HT(3), and nicotinic ACh receptors. In addition, the functional modulations by endocannabinoids of other ion-transporting membrane proteins such as transient potential receptor-class channels, gap junctions, and neurotransmitter transporters have also been reported. These findings indicate that additional molecular targets for endocannabinoids exist and that these targets may represent important sites for cannabinoids to alter either the excitability of the neurons or the response of the neuronal systems. This review focuses on the results of recent studies indicating that beyond their receptor-mediated effects, endocannabinoids alter the function of ion channels directly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16454739     DOI: 10.2174/138161206775193073

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  14 in total

1.  Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy.

Authors:  Eleonora Palma; Jorge Mauricio Reyes-Ruiz; Diego Lopergolo; Cristina Roseti; Cristina Bertollini; Gabriele Ruffolo; Pierangelo Cifelli; Emanuela Onesti; Cristina Limatola; Ricardo Miledi; Maurizio Inghilleri
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

2.  Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism.

Authors:  Mackenzie E Hofmann; Chinki Bhatia; Charles J Frazier
Journal:  J Physiol       Date:  2011-06-06       Impact factor: 5.182

3.  Orthosteric and Allosteric Activation of Human 5-HT3A Receptors.

Authors:  Noelia Rodriguez Araujo; Camila Fabiani; Albano Mazzarini Dimarco; Cecilia Bouzat; Jeremías Corradi
Journal:  Biophys J       Date:  2020-09-02       Impact factor: 4.033

Review 4.  Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas.

Authors:  Nephi Stella
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

5.  Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus.

Authors:  A Köfalvi; M F Pereira; N Rebola; R J Rodrigues; C R Oliveira; R A Cunha
Journal:  Br J Pharmacol       Date:  2007-04-16       Impact factor: 8.739

Review 6.  An overview on the biochemistry of the cannabinoid system.

Authors:  María Gómez-Ruiz; Mariluz Hernández; Rosario de Miguel; Jose A Ramos
Journal:  Mol Neurobiol       Date:  2007-06-30       Impact factor: 5.590

Review 7.  Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.

Authors:  Luciano De Petrocellis; Vincenzo Di Marzo
Journal:  J Neuroimmune Pharmacol       Date:  2009-10-22       Impact factor: 4.147

8.  Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats.

Authors:  Michael S Smirnov; Eugene A Kiyatkin
Journal:  Brain Res       Date:  2008-06-26       Impact factor: 3.252

Review 9.  Why do cannabinoid receptors have more than one endogenous ligand?

Authors:  Vincenzo Di Marzo; Luciano De Petrocellis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 10.  The therapeutic potential of novel cannabinoid receptors.

Authors:  Faith R Kreitzer; Nephi Stella
Journal:  Pharmacol Ther       Date:  2009-02-25       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.